Anti-counterfeit technologies: A pharmaceutical industry perspective

Scientia Pharmaceutica

Volumn 81, Issue 1, 2013, Pages 1-13

  Bansal, Dipika ^a   Malla, Swathi ^a   Gudala, Kapil ^a   Tiwari, Pramil ^a  

^a NATIONAL INSTITUTE OF PHARMACEUTICAL EDUCATION AND RESEARCH NIPER   (India)

Author keywords

Anti counterfeit technology; Authentication; Pedigree; RFID; Serialization

Indexed keywords

ABACAVIR PLUS LAMIVUDINE PLUS ZIDOVUDINE; AMPICILLIN PLUS CLOXACILLIN; CEFTRIAXONE; COUNTERFEIT DRUG; OXYCODONE; SILDENAFIL;

CODING; DATA BASE; DRUG INDUSTRY; DRUG MISUSE; DRUG PACKAGING; EDUCATION PROGRAM; ELECTRONIC MEDICAL RECORD; GOVERNMENT; HEALTH CARE COST; HUMAN; INVENTORY CONTROL; LEGAL LIABILITY; REVIEW; SPECTROSCOPY;

EID: 84875344835     PISSN: 00368709     EISSN: 22180532     Source Type: Journal    
DOI: 10.3797/scipharm.1202-03     Document Type: Review

References (50)

1. World Health Organization. Counterfeit medical products: Report by the secretariat. http://apps.who.int/gb/ebwha/pdf_files/WHA63/A63_23-en.pdf
2. International Policy Network. Counterfeit medicines in less developed countries: Problems and solutions. http://counterfeiting.unicri.it/docs/Ctf%20medicines%20in%20less%20developed%20countries.pdf
3. Wertheimer AI, Norris J. Safeguarding against substandard/counterfeit drugs: mitigating a macroeconomic pandemic. Res Social Adm Pharm. 2009; 5: 4-16. http://dx.doi.org/10.1016/j.sapharm.2008.05.002
4. International Medical Products Anti-Counterfeiting Taskforce. IMPACT brochure. http://www.who.int/impact/FinalBrochureWHA2008a.pdf
5. Wertheimer AI, Santella TM. Counterfeit drugs: defining the problem and finding solutions. Expert Opin Drug Saf. 2005; 4: 619-622. http://dx.doi.org/10.1517/14740338.4.4.619
6. Kshitij AS. Observatory NANO report on segment Anti-counterfeiting. http://www.observatorynano.eu/project/filesystem/files/TS%20Security%20Sub-Sector%20Anticounterfeiting%20May%2009.pdf
7. Goldhammer A, Scott ML. Pharmaceutical Supply Chain Security: a view from the pharmaceutical research and manufacturers of America. J Pharm Pract 2006; 19: 239-243. http://dx.doi.org/10.1177/0897190006293514
8. Rajivdhar. Anti-Counterfeit Packaging Technologies: A strategic need for the Indian industry. Confederation of Indian Industry, Gurgaon; 2009.
9. Sanjay M, Sanjeev W. Multiple strategies and technologies to combat counterfeit drugs. Computer Sciences Corporation, UnitedStates; 2009. http://assets1.csc.com/lef/downloads/CSCPapers2009CounterfeitDrugs.pdf
10. US Food and Drug Administration. Guidance for industry: Prescription Drug Marketing Act (PDMA) Requirements. http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM134399.pdf
11. Europe BRIDGE consortium. Problem-Analysis Report on Counterfeiting and Illicit Trade; 2007 Jul 11. http://www.bridge-project.eu/data/File/BRIDGE%20WP05%20%20Anti-Counterfeiting%20Problem%20Analysis.pdf
12. US Food and Drug Administration. Drug safety and availability: Counterfeit Drug Task Report February 2004 Update-Technology. http://www.fda.gov/Drugs/DrugSafety/ucm173297.htm
13. Lancaster I. Better Protection of Patients from the Risk of Counterfeit Medicines Public Consultation. http://ec.europa.eu/health/files/counterf_par_trade/doc_publ_consult_200803/83_international_authentication_association_en.pdf
14. Louis MP. Securing Anti-Counterfeiting Technologies. http://www.securerf.com/pdf/SecureRF_Article_Pharmaceutical_Packaging.pdf
15. Therapeutic Goods Administration. Guideline for the Tamper-Evident Packaging of Medicines, Complementary Healthcare Products and Medical Devices. http://www.tga.gov.au/pdf/archive/packaging-tamper-evident-guideline-001222.pdf
16. International Medical Products Anti-Counterfeiting Taskforce. Anticounterfeit technologies for protection of medicines. http://www.who.int/impact/events/IMPACT-ACTechnologiesv3LIS.pdf
17. Pharmaceutical Technology. Trends: Holograms and Anticounterfeiting; 2008 Apr 2. http://pharmtech.findpharma.com/pharmtech/In+the+Field/Trends-Holograms-and-Anticounterfeiting/ArticleStandard/Article/detail/505361
18. Pharmaceutical-technology. com TamperStop Security Technology-Anti-Tamper and Anti-Counterfeit Pharmaceutical Enclosures and Security Technology. http://www.pharmaceutical-technology.com/contractors/brand-protection/tamper-stop/
19. Securing Pharma. Label combines holograms, 2D holograms and thermal monitoring; 2011 Dec 14. http://www.securingpharma.com/label-combines-holograms-2d-datamatrix-and-thermal-monitoring/s40/a1151/
20. US Food and Drug Administration. Prescription Drug Marketing Act-Pedigree Requirements under 21 CFR Part 203. http://www.fda.gov/ohrms/dockets/98fr/06d-0226-gdl0001.pdf
21. Joanne SH. Drug Pedigree Rules In Effect, Yet Remain In Flux. http://www.arentfox.com/email/hawana/Drug%20Pedigree%20Rules%20In%20Effect.pdf
22. National Chain Drug Stores. Counterfeit drug task force interim report-docket number 2003n-0361. http://www.fda.gov/ohrms/dockets/dailys/03/Nov03/110603/03n-0361-c000022-vol3.pdf
23. US Food and Drug Administration. FDA counterfeit drug task force interim report. http://www.fda.gov/ohrms/dockets/dailys/03/Nov03/110603/03n-0361-c000015-01-vol3.pdf
24. National Council for Prescription Drug Programs. Drug pedigree in healthcare background. http://www.ncpdp.org/members/wg17/201001227%20NCPDP%20%20Drug%20Pedigree-Background_v1.pdf
25. US Food and Drug Administration. Anti-Counterfeit Drug Initiative Workshop and Vendor Display; Docket No. 2005N-051. http://www.fda.gov/ohrms/dockets/dockets/05n0510/05n-0510-c000004-01-vol1.pdf
26. Global Standards one. Standards Save Lives:GS1 in Healthcare. http://www.who.int/impact/activities/Van_der_Heijden.pdf
27. GS1 healthcare reference book 2011/2012. Belgium: GS1 Global Office; 2011
28. US Food and Drug Administration. Standards for securing the drug supply chain-Standardised numerical identification Prescription drug packages: Guidance for industry-final guidance. http://www.fda.gov/RegulatoryInformation/Guidances/ucm125505.htm
29. Pharmaceutical Technology Europe. Improving packaging security; 2011 May 2. http://pharmtech.findpharma.com/pharmtech/article/articleDetail.jsp?id=718108
30. Tata consultancy services. Leveraging RFID and 2D Barcodes: ePedigree and Beyond. http://www.tcs.com/SiteCollectionDocuments/White%20Papers/LSHC_WP_RFID_Technology_062009.pdf
31. Deus DBS. Technological Roles in Combating Drug Diversion and Counterfeiting. J Pharm Pract 2006; 19: 146-152. http://dx.doi.org/10.1177/0897190006292943
32. Elisabeth L, Alejandro R, Louis AL, Caroline K. Technological strategies to deal with counterfeit medicines: the European and North-American perspectives. Int J Ed Inf Technol. 2011; 5: 275-284. http://www.naun.org/journals/educationinformation/19-1164.pdf
33. Business Communications Company, Inc. Anti-Counterfeiting Packaging Technologies in the Global Pharmaceutical and Food Industries. http://www.bccresearch.com/report/anti-counterfeiting-packaging-fod042a.html
34. Felton LA, Shah PP, Sharp Z, Atudorei V, Timmins GS. Stable isotope-labeled excipients for drug product identification and counterfeit detection. Drug Dev Ind Pharm. 2011; 37: 88-92. http://dx.doi.org/10.3109/03639045.2010.492397
35. Michael P, Chen J, Lakshminarayanan S. Epothecary: Cost-effective Drug Pedigree Tracking and Authentication Using Mobile Phones. http://dx.doi.org/10.1145/1592606.1592610
36. S Mukherjee, Ushasi D. Quantum dots: An optimistic approach to novel therapeutics. Int J Pharm Sci Rev Res. 2011; 7: 59-64. http://globalresearchonline.net/journalcontents/volume7issue2/Article-010.pdf
37. Securing Pharma. Anti-counterfeiting technology patent round up; 2011 Feb 2. http://www.securingpharma.com/anticounterfeiting-technology-patent-round-up-/s40/a844/
38. Securing Pharma. Anti-counterfeiting technology patent round up; 2010 Sep 16. http://www.securingpharma.com/anti-counterfeiting-technology-patent-round-up/s40/a579/
39. Lybecker KM. Keeping it Real: Anti-counterfeiting Strategies in the Pharmaceutical Industry. Manage Decis Econ 2008;29: 389-405. http://dx.doi.org/10.1002/mde.1405
40. Purdue pharmaceuticals. Packaging update on Oxycontin 80mg. http://www.purduepharma.com/pdfs/A8070-SS%20Reformulated%20OxyContin.pdf
41. Chemical online. Applications Note: Detecting Counterfeit Pharmaceutical Using Handheld Neat-Infrared Spectroscopy http://www.chemicalonline.com/doc.mvc/Detecting-Counterfeit-Pharmaceutical-Using-0003
42. Martino R, Martino MM, Gilard V, Balayssac S. Counterfeit drugs: analytical techniques for their identification. Anal Bioanal Chem. 2010; 398: 77-92. http://dx.doi.org/10.1007/s00216-010-3748-y
43. Thayer AM. Instrumentation Firms Develop Portable Technology To Detect Counterfeit Drugs. Chem Eng News. 2012; 90: 11-15. http://cen.acs.org/magazine/90/09033.html
44. NAFDAC cares. Frequently asked questions on national anti-counterfeit mobile authentication service (MAS). http://sproxil.com/docs/NAFDAC_Sproxil_BIOFEM_MAS_FAQ.pdf
45. Pharmaceutical Exports Promotion Council. Alexandria P. GSK introduces SMS service to combat Nigerian counterfeits. http://pharmexcil.org/uploadfile/ufiles/1500880404_GSK_introduces_SMS_service_to_combat_Nigerian_counterfeits%20.pdf
46. Rahman DEA. Malaysia's Experience with Meditag. Asia Regulatory Conference on Asia's Role in Global Drug Development; 2011 April 26-28; Seoul, Republic of Korea. http://www.apec-ahc.org/files/tp201105/Dato_Eishah_A_Rahman_26April_Parallel_Track1_4pm.pdf
47. Club Inter Pharmaceutique. Data Matrix: Technical Characteristics for Traceability. http://www.cipclub.org/institutionnel/fr/real/pdf/CIP-ACL%20Les%20Cahiers%2001%20Data%20Matrix%20Tra%C3%A7abilit%C3%A9%20V%20anglaise.pdf
48. Public Health Agency of Canada. Canadian Consensus Statement on Proposed Standards for Bar Codes on Vaccine Products. http://www.phac-aspc.gc.ca/im/bar-codes-eng.php
49. Central Drug Standard Control Organisation. Deferment in the date of effect for implementation of bar-coding on export consignment of pharmaceuticals and drugs for tracing and tracking purpose. http://cdsco.nic.in/implementation_bar_coding_p_notice_59(RE-2010).htm
50. US Food and Drug Administration. PhRMA Comments on Anti-Counterfeit Drug Initiative; Docket No. 2005N-0510. http://www.fda.gov/ohrms/dockets/dockets/05n0510/05N-0510-EC25-Attach-1.pdf